Mexican Registry of Cardiomyopathies: baseline data, diagnostic strategies, and treatment approaches in Mexico

The study aimed to know the clinical, demographic, diagnostic, and treatments characteristics in patients with cardiomyopathies in Mexico. The Mexican Registry of Cardiomyopathies (REMEMI) is an observational, prospective and national study of patients with cardiomyopathies, which includes: Dilated...

Full description

Saved in:
Bibliographic Details
Published inArchivos de cardiologia de Mexico
Main Authors Llamas-Esperón, Guillermo A, Berrios-Bárcenas, Enrique A, Cossío-Aranda, Jorge E, Salmun-Nehmad, Sylvia, Morales Flores, Rahab A, Escalante-Seyffert, Maria C, Leal-Cavazos, Jorge, Sandoval-Rodríguez, Eufracino, Pamplona-Ávila, Eduardo, Sánchez-Hiza, Enrique, Ramos-Villalobos, Liliana E, Aguilera-Mora, Luisa F, Benavides-González, Mario A, Carrillo, Carlos D, Llamas-Delgado, Guillermo, Zaldívar-Zurita, Jonathan H, Matadamas-Hernández, Norberto
Format Journal Article
LanguageEnglish
Published Mexico 29.07.2024
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:The study aimed to know the clinical, demographic, diagnostic, and treatments characteristics in patients with cardiomyopathies in Mexico. The Mexican Registry of Cardiomyopathies (REMEMI) is an observational, prospective and national study of patients with cardiomyopathies, which includes: Dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), restrictive cardiomyopathy (RCM) and arrhythmogenic cardiomyopathy of the right ventricle (ARVC). A total of 1026 patients from most states of the Mexican Republic (19) were included, with 494 corresponding to DCM, 490 to HCM, 35 to RCM, and seven to ARVC. We found significant differences between the various cardiomyopathy phenotypes (p < 0.05) in the coexistence with diabetes, use of implantable defibrillator, presence of ventricular tachycardia, and NYHA functional class ≥ 1. There were no significant differences in age and predominant gender between each one. When analyzing by phenotype, we found that patients with HCM have limited use of diagnostic methods considered indispensable, such as cardiac magnetic resonance, Holter monitoring, and genetic testing in patients and their relatives. Seeking contemporary information through observational registries in Mexico is a valuable opportunity to understand the characteristics of the methods used in the study and treatment of diseases such as cardiomyopathies by Mexican physicians. It can provide information for the implementation of management guidelines and strategies to disseminate findings to improve healthcare in our country.
ISSN:1665-1731
DOI:10.24875/ACM.24000033